Prot #MN43964: A Multicenter, Single-arm, Open-label, Extension, Rollover Study to Evaluate The Long-term Safety and Efficacy of Ocrelizumab in Patients With Multiple Sclerosis

Project: Research project

Project Details

StatusActive
Effective start/end date9/22/22 → 9/22/25

Funding

  • Quintiles, Inc. (Prot #MN43964)
  • Genentech, Inc. (Prot #MN43964)